STAT3 and COVID-19: Alongside in vitro evidence, we show an age-associated rewiring of type I IFN signaling, shifting from canonical IFN responses to proinflammatory STAT3 signaling, most prominent after age 55, mirroring the age-dependent risk of severe COVID-19.